Beijing Bohui Innovation Biotechnology
Launch date
Employees
Market cap
$550m
Enterprise valuation
$671m (Public information from Sep 2024)
Share price
CNY4.8 300318.SZ
Beijing China (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 628m | 739m | 715m | 796m | 1.0b |
| % growth | - | - | - | 18 % | (3 %) | 11 % | 31 % |
| EBITDA | - | - | 129m | 133m | 11.8m | 11.2m | 186m |
| % EBITDA margin | - | - | 21 % | 18 % | 2 % | 1 % | 18 % |
| Profit | - | - | 2.5m | 7.5m | (322m) | (78.3m) | (24.9m) |
| % profit margin | - | - | - | 1 % | (45 %) | (10 %) | (2 %) |
| EV / revenue | - | - | 6.2x | 14.0x | 12.0x | 6.8x | 5.5x |
| EV / EBITDA | - | - | 30.4x | 77.9x | 727.6x | 487.1x | 31.3x |
| R&D budget | - | - | 46.6m | 48.2m | 81.5m | 64.8m | 69.2m |
| R&D % of revenue | - | - | 7 % | 7 % | 11 % | 8 % | 7 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
